PEOPLE - RayMedica (US) makes appointment to the board:
This article was originally published in Clinica
RayMedica, the US developer of a prosthetic spinal disc nucleus, has appointed Jon Jacoby to its board of directors. Mr Jacoby is currently senior executive vice-president for investment firm Stephens.
You may also be interested in...
Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from India's Glenmark.
Second read-out maintains 94% level of efficacy, with a very early signal that it could outperform Pfizer’s rival mRNA candidate in preventing severe cases.
The French major and Regeneron have racked up another indication for Dupixent with the blockbuster getting approval in Europe to treat children with severe eczema.